High-throughput fluorescent assay for inhibitor screening of proteases from rna viruses

16Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Spanish flu, polio epidemics, and the ongoing COVID-19 pandemic are the most profound examples of severe widespread diseases caused by RNA viruses. The coronavirus pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demands affordable and reliable assays for testing antivirals. To test inhibitors of viral proteases, we have developed an inexpen-sive high-throughput assay based on fluorescent energy transfer (FRET). We assayed an array of inhibitors for papain-like protease from SARS-CoV-2 and validated it on protease from the tick-borne encephalitis virus to emphasize its versatility. The reaction progress is monitored as loss of FRET signal of the substrate. This robust and reproducible assay can be used for testing the inhibitors in 96-or 384-well plates.

Cite

CITATION STYLE

APA

Cihlova, B., Huskova, A., Böserle, J., Nencka, R., Boura, E., & Silhan, J. (2021). High-throughput fluorescent assay for inhibitor screening of proteases from rna viruses. Molecules, 26(13). https://doi.org/10.3390/molecules26133792

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free